Emmanuelle Genin

Title: Innovator in Stroke Diagnostics: Emmanuelle Genin

Introduction: Emmanuelle Genin, based in Plougastel-Daoulas, France, is a pioneering inventor known for her contributions to medical diagnostics, particularly in the field of stroke evaluation and treatment. With a dedicated focus on improving patient outcomes, Genin has made significant advancements through her innovative patent.

Latest Patents: Genin holds a crucial patent titled "Blood biomarkers of stroke." This invention encompasses a method for diagnosing a stroke, assessing the likelihood of a subject responding to therapy, identifying individuals at risk of having a stroke, and providing treatment methods. The diagnostic process involves determining a signature in samples obtained from subjects by measuring the expression levels of at least two biomarkers, including PTGS2, HMOX1, LDLR, HSPA1B, G0S2, BAG3, TM4SF1, DUSP1, and ADM.

Career Highlights: Throughout her career, Emmanuelle Genin has worked with esteemed institutions such as the Centre Hospitalier Régional et Universitaire de Brest and the Établissement Français du Sang. Her clinical and research experiences have deeply informed her innovations, allowing her to merge theoretical knowledge with practical applications in healthcare.

Collaborations: Genin has collaborated with notable professionals in her field, including her coworker Serge Timsit. These partnerships have facilitated the advancement of her research, fostering an environment of knowledge exchange that benefits the scientific community.

Conclusion: Emmanuelle Genin's contributions to the medical field through her innovative patent on stroke diagnostics demonstrate her commitment to enhancing patient care. Her work not only offers promising therapeutic pathways but also emphasizes the importance of research and collaboration in driving healthcare innovations forward.